Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

DILI × abemaciclib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 86 Neoplasm Metastasis 22 Neoplasms 10 Brain Neoplasms 10 Prostatic Neoplasms 9 Endometrial Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Glioblastoma 7 Ovarian Neoplasms 6 Triple Negative Breast Neoplasms 5 Glioma 5 Sarcoma 4 Recurrence 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Colorectal Neoplasms 4 Sarcoma, Ewing 3 Osteosarcoma 3 Multiple Myeloma 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Breast Diseases 3 Unilateral Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Neuroblastoma 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma 2

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡